Journal of Peking University(Health Sciences) ›› 2017, Vol. 49 ›› Issue (3): 547-550. doi: 10.3969/j.issn.1671-167X.2017.03.029

• Article • Previous Articles     Next Articles

Distant metastases of malignant salivary gland carcinoma after treated by 125Ⅰinternal brachy therapy alone

WANG Wei, ZHENG Lei, LIU Shu-ming, HUANG Ming-wei, SHI Yan, LV Xiao-ming, ZHANG Jie△, ZHANG Jian-guo   

  1. (Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Engi-neering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China)
  • Online:2017-06-18 Published:2017-06-18
  • Contact: ZHANG Jie E-mail:zhangjie06@126.com

Abstract: Objective: To investigate clinical features of distant metastases from malignant salivary gland carcinomas after treated by 125I internal brachy therapy alone. Methods: Between 2002 and 2010, 43 patients with locally advanced unresectable or recurrent malignant salivary gland carcinomas were treated by 125I internal brachy therapy alone at Peking University School and Hospital of Stomatology. All of them had been follow-up at least 2 years. The primary sites of malignant salivary gland carcinomas were the parotid for 12 patients, infratemporal fossa for 9 patients, tongue for 7 patients, maxilla for 6 patients, parapharyngeal for 4 patients, floor of months for 3 patients, submandibular gland for 1 patient, and lip for 1 patient. The overall survival rate, local control rate, and distant metastases were retrospectively reviewed. Results: Distant metastases occurred in 23 of the 43 patients (53.5%). Distant metastases developed from 5 to 96 months, with an average interval of (27.0±23.7) months from the time of initial diagnosis, the mean interval was 21 months. The commonest site of distant metastases overall was the lung 69.6%(16/23). The most common pathological types of distant metastases were adenoid cystic carcinoma (14/23, 60.9%) and nonspecific adenocarcinoma (7/23, 30.4%). At the time of the last follow-up, 26 patients died, and 18 of them due to distant metastases (69.2%, 18/26). In the study, 27 patients got complete remission(CR), 12 got partial remission(PR) more than 50%, 2 less than 50%, and 2 patients were invalid. The effective rate (CR+ PR) was 90.7%. The 3 year loco-regional control rate and survival rate were 60.1%, 82.6%, respectively, and the 5 year’s 53.4% and 56.0%. Conclusion: The 125I brachy therapy is a feasible and effective modality for the treatment of locally advanced unresectable or recurrent malignant salivary gland carcinomas. However, further studies are needed with larger numbers of patients and for a longer follow-up assessment. Distant metastasis was the main cause of treatment failure, and the lung was the most common site of distant metastases.

Key words: Head and neck neoplasms, Salivary gland neoplasms, Neoplasm metastasis, Brachy therapy, Iodine radioisotopes

CLC Number: 

  •  
[1] Huan-bin YU,Wen-jie WU,Xiao-ming LV,Yan SHI,Lei ZHENG,Jian-guo ZHANG. 125I seed brachytherapy for recurrent salivary gland carcinoma after external radiotherapy [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 919-923.
[2] Xiao LI,Jia-zeng SU,Yan-yan ZHANG,Li-qi ZHANG,Ya-qiong ZHANG,Deng-gao LIU,Guang-yan YU. Inflammation grading and sialoendoscopic treatment of131I radioiodine-induced sialadenitis [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 586-590.
[3] Xu-chu ZHANG,Jian-hua ZHANG,Rong-fu WANG,Yan FAN,Zhan-li FU,Ping YAN,Guang-yu ZHAO,Yan-xia BAI. Diagnostic value of 18F-FDG PET/CT and tumor markers (CEA, CA19-9, CA24-2) in recurrence and metastasis of postoperative colorectal moderately differentiated adenocarcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1071-1077.
[4] Cong LI,Shu-ming LIU,Lei ZHENG,Ming-wei HUANG,Yan SHI,Xiao-ming LV,Jian-guo ZHANG,Jie ZHANG. Study of surgery combined with 125I brachytherapy for adenoid cystic carcinoma of oral and maxillofacial region [J]. Journal of Peking University(Health Sciences), 2019, 51(1): 49-52.
[5] HUANG Zi-xiong, DU Yi-qing, ZHANG Xiao-peng, LIU Shi-jun, XU Tao. Clinical and pathological analysis of renal cell carcinoma bone metastasis [J]. Journal of Peking University(Health Sciences), 2018, 50(5): 811-815.
[6] HUANG Zi-xiong, ZHANG Xiao-peng, DONG Sen, LIU Shi-jun, YANG Rong-li, ZHOU Yu-shi, MA Wei-guo. Renal mucinous tubular and spindle cell carcinoma combined with multiple bone metastasis: a case report and literature review [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 732-735.
[7] YE Ke-qiang, HUANG Ming-wei, LI Jun-li, TANG Jin-tian, ZHANG Jian-guo. Simulation of dose distribution in bone medium of 125I photon emitting source with Monte Carlo method [J]. Journal of Peking University(Health Sciences), 2018, 50(1): 131-135.
[8] LI Jian-nan, FENG Zhi-en, WANG Lin, WANG Yi-xiang, GUO Chuan-bin. Expression of hypoxiainducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma [J]. Journal of Peking University(Health Sciences), 2018, 50(1): 26-32.
[9] ZHAO Yi-guo, YANG Xiao-dong, ZHANG Yan-kai, NING Ning, XING Zhao-dong, YE Ying-jiang. #br# Adenocarcinoma in a Meckel’s diverticulum with multiple liver metastases and gastrointestinal hemorrhage: a case report [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1095-1097.
[10] YU Yao, ZHANG Wen-bo, WANG Yang, LIU Xiao-jing, GUO Chuan-bin, YU Guang-yan, PENG Xin. Application of three-dimensional reconstruction of the enhanced CT with iPlan CMF software in head and neck neoplasms [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 878-882.
[11] GUO Fu-xin, JIANG Yu-liang, JI Zhe, PENG Ran, SUN Hai-tao, WANG Jun-jie. 3D printed template-assisted and computed tomography image-guided 125-iodine seed implantation for supraclavicular metastatic tumor: a dosimetric study [J]. Journal of Peking University(Health Sciences), 2017, 49(3): 506-511.
[12] FANG Wei-gang, TIAN Xin-xia. Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP [J]. Journal of Peking University(Health Sciences), 2017, 49(2): 188-195.
[13] QIN Cai-peng,LIU Chun-lei, ZHAO Yan-hui, YIN Hua-qi, DU Yi-qing, HU Feng-zhan, SHENG Zheng-zuo, XU Tao. Expression of MEK/ERK signal pathways in renal cell carcinoma with bone metastasis [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 590-593.
[14] SHAO Bin, LI Hui-ping, DI Li-jun, SONG Guo-hong, JIANG Han-fang, LIANG Xu, WANG Chao-ying, YAN Ying, LIN Xiao-lin, WANG Li-na, WAN Feng-ling, YUAN Yan-hua, YOU Miao-ning. Predictive and prognostic value of monitoring lymphocyte subsets in peripheral blood before and after chemotherapy in patients with metastatic breast cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(2): 304-309.
[15] GUO Yu-xing, WANG Dian-can, WANG Yang, PENG Xin, MAO Chi, GUO Chuan-bin. Clinical features of osteonecrosis of jaws after bisphosphonates therapy for bone metastasis of breast cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(1): 80-83.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 158 -161 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 109 -111 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 505 -515 .
[10] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 599 -601 .